Report Detail

Pharma & Healthcare Birch Pollen Allergy - Pipeline Review, H1 2019

  • RnM2890037
  • |
  • 06 February, 2019
  • |
  • Global
  • |
  • 42 Pages
  • |
  • Global Markets Direct
  • |
  • Pharma & Healthcare

Birch Pollen Allergy - Pipeline Review, H1 2019

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Birch Pollen Allergy - Pipeline Review, H1 2019, provides an overview of the Birch Pollen Allergy (Immunology) pipeline landscape.

Birch pollen allergy is a reaction which occurs soon after exposure to pollen of birch trees. Signs and symptoms include skin reactions, such as hives, redness or swelling, itching or tingling in or around the mouth and throat, digestive problems, such as diarrhea, stomach cramps, nausea or vomiting, tightening of the throat, shortness of breath or wheezing and runny nose. Predisposing factors include age, family history and other allergies. Treatment includes drugs belonging to class of antihistamines.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Birch Pollen Allergy - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Birch Pollen Allergy (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Birch Pollen Allergy (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Birch Pollen Allergy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Preclinical and Discovery stages are 2, 2, 3 and 2 respectively.

Birch Pollen Allergy (Immunology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Birch Pollen Allergy (Immunology).
- The pipeline guide reviews pipeline therapeutics for Birch Pollen Allergy (Immunology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Birch Pollen Allergy (Immunology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Birch Pollen Allergy (Immunology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Birch Pollen Allergy (Immunology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Birch Pollen Allergy (Immunology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Birch Pollen Allergy (Immunology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.


Table of Contents

    List of Tables

      List of Figures

        Introduction

          Global Markets Direct Report Coverage

            Birch Pollen Allergy - Overview

              Birch Pollen Allergy - Therapeutics Development

                Pipeline Overview

                  Pipeline by Companies

                    Products under Development by Companies

                      Birch Pollen Allergy - Therapeutics Assessment

                        Assessment by Route of Administration

                          Assessment by Molecule Type

                            Birch Pollen Allergy - Companies Involved in Therapeutics Development

                              ALK-Abello AS

                                Allergy Therapeutics Plc

                                  Anergis SA

                                    Biomay AG

                                      Desentum Oy

                                        HAL Allergy BV

                                          Laboratorios LETI SL

                                            S-TARget therapeutics GmbH

                                              Birch Pollen Allergy - Drug Profiles

                                                Allergen for Allergic Rhinitis, Allergic Rhino-Conjunctivitis and Birch Pollen Allergy - Drug Profile

                                                  Product Description

                                                    Mechanism Of Action

                                                      R&D Progress

                                                        Allergen for Birch Pollen Induced Allergic Rhinoconjunctivitis - Drug Profile

                                                          Product Description

                                                            Mechanism Of Action

                                                              R&D Progress

                                                                birch pollen allergen extract - Drug Profile

                                                                  Product Description

                                                                    Mechanism Of Action

                                                                      R&D Progress

                                                                        BM-31 - Drug Profile

                                                                          Product Description

                                                                            Mechanism Of Action

                                                                              R&D Progress

                                                                                PL-102 - Drug Profile

                                                                                  Product Description

                                                                                    Mechanism Of Action

                                                                                      R&D Progress

                                                                                        Pollinex Quattro Birch - Drug Profile

                                                                                          Product Description

                                                                                            Mechanism Of Action

                                                                                              R&D Progress

                                                                                                SG-300 - Drug Profile

                                                                                                  Product Description

                                                                                                    Mechanism Of Action

                                                                                                      R&D Progress

                                                                                                        Vaccine for Birch Pollen Allergy - Drug Profile

                                                                                                          Product Description

                                                                                                            Mechanism Of Action

                                                                                                              R&D Progress

                                                                                                                Vaccines For Birch Pollen Allergy - Drug Profile

                                                                                                                  Product Description

                                                                                                                    Mechanism Of Action

                                                                                                                      R&D Progress

                                                                                                                        Birch Pollen Allergy - Dormant Projects

                                                                                                                          Birch Pollen Allergy - Discontinued Products

                                                                                                                            Birch Pollen Allergy - Product Development Milestones

                                                                                                                              Featured News & Press Releases

                                                                                                                                Dec 13, 2018: Anergis reports positive preclinical proof-of concept data of the Second-Generation COP Allergy Vaccine

                                                                                                                                  Sep 05, 2018: Anergis initiates development of second-generation COP Allergy Vaccines; announces publication of sustained efficacy data from Ph. IIb study follow-Up

                                                                                                                                    Aug 14, 2018: HAL Allergy first company to achieve marketing authorisations in line with Therapieallergene-Verordnung (TAV) in Germany

                                                                                                                                      May 27, 2018: Allergy experts: Clinical effect of ALK's tree SLIT-tablet among the most significant ever seen in allergy immunotherapy trials

                                                                                                                                        Jun 14, 2017: Desentum has two presentations in EAACI 2017

                                                                                                                                          May 10, 2017: Desentum is preparing to start clinical trials with birch pollen allergy vaccine

                                                                                                                                            Mar 16, 2017: Allergy Therapeutics Announces First Patient Recruited in Pivotal Phase III Birch Immunotherapy B301 Study

                                                                                                                                              May 17, 2016: HAL Allergy has successfully completed its Phase III short-term efficacy trial with its sublingual allergen immunotherapy (SLIT) liquid product for the treatment of birch pollen allergy

                                                                                                                                                May 09, 2016: Allergy Therapeutics Announces Positive Top-Line Results From the PQBirch204 Phase II Study for Birch-Induced Seasonal Allergic Rhinitis

                                                                                                                                                  Sep 01, 2015: First patient recruited in Pollinex Quattro Birch dose ranging study in Germany and Austria

                                                                                                                                                    Mar 10, 2015: Positive Outcome of the PURETHAL Birch RUSH Study Results in an Approved, Accelerated up-dosing Regimen

                                                                                                                                                      May 12, 2013: Desentum: EARTO innovation prize to VTT

                                                                                                                                                        Mar 09, 2006: Stallergenes Reports Positive Study Results with Biomay´s Bet v 1

                                                                                                                                                          Appendix

                                                                                                                                                            Methodology

                                                                                                                                                              Coverage

                                                                                                                                                                Secondary Research

                                                                                                                                                                  Primary Research

                                                                                                                                                                    Expert Panel Validation

                                                                                                                                                                      Contact Us

                                                                                                                                                                        Disclaimer

                                                                                                                                                                        Summary:
                                                                                                                                                                        Get latest Market Research Reports on Birch Pollen Allergy. Industry analysis & Market Report on Birch Pollen Allergy is a syndicated market report, published as Birch Pollen Allergy - Pipeline Review, H1 2019. It is complete Research Study and Industry Analysis of Birch Pollen Allergy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

                                                                                                                                                                        Last updated on

                                                                                                                                                                        REPORT YOU MIGHT BE INTERESTED

                                                                                                                                                                        Purchase this Report

                                                                                                                                                                        $2,000.00
                                                                                                                                                                        $4,000.00
                                                                                                                                                                        $6,000.00
                                                                                                                                                                        1,584.00
                                                                                                                                                                        3,168.00
                                                                                                                                                                        4,752.00
                                                                                                                                                                        1,848.00
                                                                                                                                                                        3,696.00
                                                                                                                                                                        5,544.00
                                                                                                                                                                        302,580.00
                                                                                                                                                                        605,160.00
                                                                                                                                                                        907,740.00
                                                                                                                                                                        166,740.00
                                                                                                                                                                        333,480.00
                                                                                                                                                                        500,220.00
                                                                                                                                                                        Credit card Logo

                                                                                                                                                                        Related Reports


                                                                                                                                                                        Reason to Buy

                                                                                                                                                                        Request for Sample of this report